Cell-free Assays (IC50/Ki) for BI-10773 (Empagliflozin)

Key TargetIC50 (Cell-free)DescriptionReference
SGLT1 8300 nM Half maximal inhibitory concentration (IC50) measurement Download PDF
SGLT2 3.1 nM Half maximal inhibitory concentration (IC50) measurement Download PDF
hSGLT2 3.1 nM SGLT2 inhibition assay PMC7554656
mSGLT2 1.9 nM SGLT2 inhibition assay PMC7554656
SMIT-1 8.3 mM Estimated Download PDF

Cell-based Assay (IC50) for BI-10773 (Empagliflozin)

Cell TypeIC50 (Cell-based)DescriptionReference
Human cardiomyocytes 76.14 nM ELISA assays for CXCL10 release, followed by dose-response curve analysis. Download PDF
Recombinant human Nav1.5 α-subunit (expressed in HEK293T cells) 0.79 µmol/L Whole-cell patch-clamp recordings of peak- and late-INa, H2O2-induced late-INa. Download PDF
SGLT2 3.1 nM SGLT inhibition assay (cited from Grempler et al., 2012) Download PDF
SGLT1 8,300 nM SGLT inhibition assay (cited from Grempler et al., 2012) Download PDF
Check the BI-10773 (Empagliflozin) product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.

Jump to